AQEMIA
Aqemia is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases. Our differentiation lies in our unique quantum and statistical mechanics algorithms fueling a generative artificial intelligence to design novel drug candidates. The disruptive speed and accuracy of our technological platform enables us to scale drug discovery projects just like tech projects.
AQEMIA
Social Links:
Industry:
Artificial Intelligence Biotechnology Machine Learning Pharmaceutical Quantum Computing
Founded:
2019-06-13
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.aqemia.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.42 M USD
Technology used in webpage:
Euro Google Google Cloud Google Cloud Global Multi-Region
Similar Organizations
Clyde Biosciences
Improving success in drug discovery
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.aqemia.com Semrush global rank: 9.35 M Semrush visits lastest month: 169
- Host name: any-in-2215.1e100.net
- IP address: 216.239.34.21
- Location: Mexico City Mexico
- Latitude: 19.3421
- Longitude: -99.1927
- Timezone: America/Mexico_City
- Postal: 01090
More informations about "Aqemia" on Search Engine
AQEMIA - Crunchbase Company Profile & Funding
Aqemia is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for …See details»
Aqemia - Careers
Careers. At Aqemia you will work in a multi-disciplinary team of passionate drug hunters, AI engineers and developers who are committed to our mission of finding many drugs, at …See details»
AQEMIA | LinkedIn
Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of...See details»
Aqemia wins $32.5m for generative AI-powered drug discovery …
Jan 30, 2024 Paris-based biotech Aqemia has secured €30m ($32.5m) in Series A funding to advance its generative artificial intelligence (AI)-led drug pipeline. The company …See details»
AQEMIA Boosts Series A Funding to €60M to Accelerate on its …
Jan 30, 2024 AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug …See details»
AQEMIA Announces a Major Multi-year Collaboration of $140 …
Business Wire. Tue, Dec 5, 2023 2 min read. In this article: SAN.PA. This collaboration aims at accelerating the discovery of small molecules across various therapeutic areas, …See details»
Aqemia Raises €30M to Scale its Deep Physics and AI Enabled …
Oct 19, 2022 Aqemia is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug …See details»
Aqemia Announces an Extension of Its First ... - Business Wire
June 15, 2022 04:24 PM Eastern Daylight Time. PARIS-- ( BUSINESS WIRE )--Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum physics …See details»
Aqemia and Servier announce AI and quantum physics-drive …
PARIS, France, Dec. 16, 2021 /PRNewswire/ -- Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum physics, and Servier, a global …See details»
AQEMIA Announces a Major Multi-year Collaboration of $140 …
Dec 5, 2023 AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi | Business Wire. This collaboration aims at accelerating the discovery of small …See details»
AQEMIA Boosts Series A Funding to €60M to Accelerate on its …
On Jan 31, 2024. AQEMIA continues to grow rapidly in its effort to discover new drugs with their generative-AI fueled by deep physics. After raising €30M last year, the tech-enabled …See details»
AQEMIA Announces a Major Multi-year Collaboration of $140 …
05-Dec-2023. AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi. This collaboration aims at accelerating the discovery of small molecules across various therapeutic areas, leveraging its unique Deep Physics platform combined with …See details»
AQEMIA - Medium
Jacques Boitreaud. Feb 21, 2022. Aqemia is a next-gen pharmatech company generating one of the world’s fastest-growing drug discovery pipeline thanks to our unique quantum …See details»
AQEMIA - Updates, News, Events, Signals & Triggers - Crunchbase
News Insight Details. Powered by AI. Paris-based biotech AQEMIA, specializing in AI-driven drug discovery, has successfully raised an additional €30m in Series A funding. This increase brings their total Series A funding to €60m.See details»
Gen AI and quantum to design new drugs: Paris-based Aqemia …
Jan 30, 2024 Paris-based biotech Aqemia, which uses AI to fast-track drug discovery and design, has raised a €30m extension to its Series A, bringing total funding for the round …See details»
Aqemia Raises Additional €30M in Series A - finsmes.com
Jan 30, 2024 Aqemia, a Paris, France-based tech-enabled drug discovery company, raised additional €30M in Series A funding. The round, which brought the total amount to …See details»
AQEMIA Boosts Series A Funding to €60M to Accelerate on its …
Jan 30, 2024 AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug …See details»
AQEMIA - Funding, Financials, Valuation & Investors - Crunchbase
Oct 17, 2020 Organization. AQEMIA. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 4. Total …See details»
Aqemia Announces an Extension of its First Collaboration With …
James Dargan. June 14, 2022. Image by Arek Socha from Pixabay. PRESS RELEASE — PARIS, France, June 14, 2022 — Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum physics announced today that it has entered a new research collaboration with Sanofi.See details»
Aqemia, spin-off ENS - PSL
Aqemia is a spin-off startup from the École normale supérieure – PSL, specialized in drug discovery. On December 10, it received support and funding from Sanofi, a leader in the …See details»